UnitedHealth’s $3.3B Deal for Amedisys Gets Antitrust Review

UnitedHealth Group’s $3.29 billion takeover of Amedisys will undergo an in-depth antitrust review by the Department of Justice, according to a filing from Amedisys. The home-health company disclosed in a regulatory filing that it received a so-called second request seeking additional information on the deal from the antitrust agency on Aug. 4, Bloomberg reports. Read more.

Total
0
Shares
Related Posts
Read More

PA Lawmakers go After UPMC

The American Economic Liberties Project, a nonpartisan organization established in 2020, published an 18-page report on the nonprofit health system, titled "Critical Condition: How UPMC's Monopoly Power Harms Workers and Patients."